Puromycin selectively increases mdr1a expression in immortalized rat brain endothelial cell lines

Journal of Neurochemistry

Volumn 88, Issue 1, 2004, Pages 23-31

  Demeuse, P ^a   Fragner, P ^a   Leroy Noury, C ^a   Mercier, C ^a   Payen, L ^b   Fardel, O ^b   Couraud, P O ^c   Roux, F ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Blood brain barrier; GPNT cell line; In vitro model; P glycoprotein; Puromycin

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; PUROMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL IMMORTALIZATION; CHRONOPHARMACOLOGY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC TRANSFECTION; IN VITRO STUDY; LIPID SOLUBILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALIA; RODENTIA;

EID: 0347363616     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02071.x     Document Type: Article

References (39)

1. Abbott N. J. and Romero I. A. (1996) Transporting therapeutics across the blood-brain barrier. Mol. Med. Today 2, 106-113.
2. Allen J. D., Brinkhuis R. F., Wijnholds J. and Schinkel A. H. (1999) The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxombicin. Cancer Res. 59, 42374-241.
3. Barrand M. A., Robertson K. J. and von Weikersthal S. F. (1995) Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett. 374, 179-183.
4. Bates S. E., Robcy R., Miyake K., Rao K., Ross D. D. and Litman T. (2001) The role of half-transporters in multidrug resistance. J. Bioenerg. Biomembr. 33, 503-511.
5. Begley D. J., Lechardeur D., Chen Z.-D., Rollinson C., Bardoul M., Roux F., Scherman D. and Abbott N. J. (1996) Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J. Neurochem. 67, 988-995.
6. Bourgeois S., Gruol D. J., Newby R. F. and Rajah F. M. (1993) Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol. Endocrinol. 7, 840-851.
7. Bryan T. M. and Reddel R. R. (1994) SV40-induced immortalization of human cells. Crit. Rev. Oncog. 5, 331-335.
8. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Eisenblätter T. and Galla H.-J. (2002) A new multidrug resistance protein at the blood-brain barrier. Biochem. Biophys. Res. Commun. 293, 1273-1278.
10. El Hafny B., Cano N., Piciotti M., Regina A., Scherrmann J.-M. and Roux F. (1997) Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line. Biochem. Pharmacol. 53, 1735-1742.
11. Fardel O., Lecureur V. and Guillouzo A. (1996) The P-gp multidrug transporter. Gen. Pharmacol. 27, 1283-1291.
12. Fenart L., Buee-Scherrer V., Descamps L., Duhem C., Poullain M. G., Cechelli R. and Dehouck M. P. (1998) Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. Pharm. Res. 15, 993-1000.
13. Greenwood J. (1992) Characterisation of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J. Neuroimmunol. 39, 123-132.
14. Greenwood J., Pryce G., Devine L., Male D. K., dos Santos W. L. C., Calder V. L. and Adamson P. (1996) SV40 large-T immortalised cell lines of the rat blood-brain barriers retain their phenotypic and immunological characteristics. J. Neuroimmunol. 71, 51-63.
15. Huwyler J., Drewe J., Klusemann C. and Fricker G. (1996) Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br. J. Pharmacol. 118, 1879-1885.
16. Hsu S. I., Lothstein L. and Horwitz S. B. (1989) Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J. Biol. Chem. 264, 12 053-12 062.
17. Iordanov M. S., Pribnow D., Magun J. L., Dinh T.-H., Pearson J. A., Chen S. L.-Y. and Magun B. E. (1997) Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Molec. Cell. Biol. 17, 3373-3381.
18. Jette L., Murphy G. F., Leclerc J. and Beliveau R. (1995) Interaction of drugs with P-glycoprotein in brain capillaries. Biochem. Pharmacol. 50, 1701-1709.
19. Litman T., Druley T. E., Stein W. D. and Bates S. E. (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol. Life Sci. 58, 931-959.
20. Lothstein L., Hsu S. I., Horwitz S. B. and Greenberger L. M. (1989) Alternate overexpression of two phosphoglycoprotein genes is associated with changes in multidrug resistance in a J774.2 cell line. J. Biol. Chem. 264, 16 054-16 058.
21. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. McClean S., Whelan R. D., Hosking L. K., Hodges G. M., Thompson F. H., Meyers M. B., Schuurhuis G. J. and Hill B. T. (1993) Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in-vitro exposure to fractionated X-irradiation. Biochim. Biophys. Acta 1177, 117-126.
23. Miller D. S., Nobmann S. N., Gutmann H., Toeroek M., Drewe J. and Fricker G. (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58, 1357-1367.
24. Ng W. F., Sarangi F., Zastawny R. L., Veinot-Drebot L. and Ling V. (1989) Identification of members of the P-glycoprotein multigene family. Mol. Cell Biol. 9, 1224-1232.
25. 2-terminal protein kinase pathway in the cellular response to adriamycine and other chemotherapeutic drugs. J. Biol. Chem. 271, 30950-30955.
26. Regina A., Koman A., Piciotti M., El Hafny B., Center M. S., Bergmann R., Couraud P. O. and Roux F. (1998) Mrp1 multi-drug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71, 705-715.
27. Regina A., Romero I. A., Greenwood J., Adamson P., Bourre J. M., Couraud P. O. and Roux F. (1999) Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT. J. Neurochem. 73, 1954-1963.
28. Schinkel A. H. (1999) P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 179-194.
29. Schinkel A. H., Smit J. J. M., van Tellingen O. et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
30. Schott B., Bennis S., Pourquier P., Ries C., Londos-Gagliardi D. and Robert J. (1993) Differential over-expression of mdrl genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine. Int. J. Cancer. 55, 115-121.
31. Shapiro A. B. and Ling V. (1995) Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270, 16 167-16 175.
32. Sidhu J. S. and Omiecinski J. O. (1998) Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocytes. J. Biol. Chem. 273, 47694-775.
33. Sukhai M. and Piquette-Miller M. (2000) Regulation of the multidrug resistance genes by stress signals. J. Pharm. Pharmaceut. Sci. 3, 262-280.
34. Tang-Wai D. F., Kajiji S., DiCapua F., de Graaf D., Roninson I. B. and Gros P. (1995) Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34, 32-39.
35. Tatsuta T., Naito M., Oh-hara T., Sugarawa I. and Tsuruo T. (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267, 20 383-20 391.
36. Teeter L. D., Estes M., Chan J. Y., Atassi H., Sell S., Becker F. F. and Kuo M. T. (1996) Activation of distinct multidrug resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinogen 8, 67-73.
37. Thottassery J. V., Zambetti G. P., Arimori K., Schuetz E. G. and Schuetz J. D. (1997) p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc. Natl. Acad. Sci. USA 94, 11 037-11 042.
38. Vara J., Perez-Gonzalez J. A. and Jimenez A. (1985) Biosynthesis of puromycin by Streptomyces alboniger: characterization of puromycin N-acetyltransferase. Biochemistry 24, 8074-8081.
39. Yamazaki M., Neway W. E., Ohe T., Chen I.-W., Rowe J. F., Hochman J. H., Chiba M. and Lin J. H. (2001) In vitro substrate identification studies for P-glycoprotein-mediated transport: species difference and predictability of in vivo results. J. Pharmacol. Exp. Ther. 296, 723-735.